The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 102.00
Ask: 106.00
Change: -1.50 (-1.42%)
Spread: 4.00 (3.922%)
Open: 105.50
High: 105.50
Low: 104.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

16 Sep 2020 15:40

RNS Number : 2148Z
Intercede Group PLC
16 September 2020
 

Intercede Group plc

 

Result of Annual General Meeting ("AGM")

 

 

 

The AGM of Intercede Group plc was held on Wednesday 16 September 2020 at 2.00 pm.

 

All resolutions were passed on a poll. Resolutions 1 to 5 were passed as ordinary business and resolutions 6 to 9 were passed as special business. The number of ordinary shares in issue is 50,523,926.

 

 

For

% of votes cast

Against

% of votes cast

Withheld

 

Ordinary Business

1. To receive and to adopt the Company's financial statements for the year ended 31 March 2020 together with the reports of the Directors and the auditors.

22,094,062

100.00

-

-

-

2. To re-elect Klaas van der Leest as a director.

22,094,062

100.00

-

-

-

3. To re-elect Royston Hoggarth as a director.

19,885,592

90.00

2,208,470

10.00

-

4. To re-elect Jacques Tredoux as a director.

19,894,892

90.05

2,199,170

9.95

-

5. To re-appoint PricewaterhouseCoopers LLP to hold office as auditors until the next Annual General Meeting, and to authorise the Directors to determine the remuneration of the auditors.

22,094,062

100.00

-

-

-

 

Special Business

6. To renew the authority given to the Directors to allot new securities.

22,086,139

100.00

-

-

7,923

7. That the Directors be given power (subject to the passing of resolution 6) to allot for cash equity securities (as defined in section 560(1) of the Act for the purposes of section 561 of the Act).

22,073,139

99.94

13,000

0.06

7,923

 

8. That, in accordance with article 10 of the Company's articles of association and the Act, the Company is generally and unconditionally authorised to make market purchases (within the meaning of section 693 of the Act) of ordinary shares of 1 pence each in the capital of the Company (Ordinary Shares).

22,060,082

99.88

26,057

0.12

7,923

9. To authorise the Directors to call general meetings (other than Annual General Meetings) on not less than 14 days' notice.

22,060,139

99.88

26,000

0.12

7,923

 

The votes "for" figures include those votes at the discretion of the Chairman. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

 

Intercede Group plc will also publish this information on its website at www.intercede.com.

 

Enquiries

 

Intercede Group plcTel.+44 (0)1455 558111Klaas van der Leest, Chief ExecutiveAndrew Walker, Finance Director

 

finnCapTel.+44 (0)207 220 0500Stuart Andrews, Corporate FinanceSimon Hicks, Corporate Finance

 

 

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

For more information visit: www.intercede.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGKKABNQBKDNCD
Date   Source Headline
25th Sep 20131:00 pmRNSResult of AGM
25th Sep 20137:00 amRNSContract Wins and AGM Statement
9th Sep 20137:00 amRNSDirectors' Holding
29th Jul 20137:00 amRNSContract awards and Trading update
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
4th Jun 20137:00 amRNSFinal Results
25th Apr 20137:00 amRNSContract Win
16th Apr 20137:00 amRNSAppointment of Non-Executive Director
5th Apr 20137:00 amRNSYear end trading update
1st Feb 20137:00 amRNSTrading Update
3rd Dec 20127:00 amRNSHolding(s) in Company
22nd Nov 20127:00 amRNSInterim Results
4th Oct 20127:00 amRNSTrading Update
26th Sep 20124:39 pmRNSResult of AGM
21st Aug 20127:00 amRNSAmendments to LTIP
4th Jul 20123:35 pmRNSDirector/PDMR Shareholding
14th Jun 20122:37 pmRNSIssue of Equity
12th Jun 201210:13 amRNSDirector/PDMR Shareholding and Issue of equity
5th Apr 20127:00 amRNSYear End Trading Update
15th Mar 20121:02 pmRNSIssue of Equity
17th Feb 20127:00 amRNSDirector/PDMR Shareholding
16th Feb 20127:00 amRNSTrading Update
12th Dec 20117:00 amRNSUS Expansion
7th Dec 201112:00 pmRNSSales Alliance
1st Dec 20117:00 amRNSInterim Results
14th Nov 20117:00 amRNSNew Partnership
4th Oct 20117:00 amRNSNew Contract Win
21st Sep 20112:55 pmRNSResult of AGM
21st Sep 20117:00 amRNSAGM Statement and Update
17th Aug 20117:00 amRNSDirector/PDMR Share Option Awards
4th Aug 20113:39 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSTrading Update
18th Jan 20119:32 amRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSTransaction in Own Shares
30th Nov 201011:02 amRNSAdditional Listing and Director dealing
29th Nov 20107:00 amRNSIntercede Group Interim Results
4th Nov 20107:00 amRNSReduction of Share Capital
7th Oct 20107:54 amRNSPositive Trading Update
30th Sep 20107:00 amRNSNew Contract Win
24th Sep 20102:00 pmRNSResult of AGM
22nd Sep 20107:00 amRNSNew Contract Win
7th Sep 20107:00 amRNSPositive Trading Update
15th Jul 20107:00 amRNSLaunch of latest version of MyID PIV
6th Jul 20103:48 pmRNSChange of name of adviser
10th Jun 20107:00 amRNSFinal Results
8th Apr 20107:00 amRNSTrading Update
25th Mar 201012:30 pmRNSSettlement of Patent Dispute
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
1st Mar 20102:00 pmRNSMajor Subcontract with Thales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.